Published in J Natl Cancer Inst on March 15, 1989
Detection and characterization of carcinoma cells in the blood. Proc Natl Acad Sci U S A (1998) 4.76
Sexual adjustment, identification, and attitudes of patients with myelopathy. Arch Phys Med Rehabil (1966) 1.50
Peripheral blood tumor cell load reflects the clinical activity of the disease in patients with carcinoma of the breast. Int J Oncol (2000) 1.05
Regulation of beta-cell mass and function by the Akt/protein kinase B signalling pathway. Diabetes Obes Metab (2007) 0.99
Varied appearance of AIDS-related lymphoma in the chest. Radiology (1989) 0.94
Experience with the use of adriamycin in combination with other anticancer agents using a weekly schedule, with particular reference to lack of cardiac toxicity. Cancer (1977) 0.89
Protection of mice against 7,12-dimethylbenz(a)anthracene-induced skin tumors by immunization with a fluorinated analog of the carcinogen. Cancer Res (1981) 0.89
Management of brachial plexus tumors. Arch Otolaryngol (1977) 0.87
A phase I study of emetine hydrochloride (NSC 33669) in solid tumors. Cancer (1973) 0.86
Phase II study of 5-azacytidine in solid tumors. Cancer Treat Rep (1977) 0.84
Combination phase 1-II study of imidazole carboxamide (NCS45388). Oncology (1972) 0.84
Streptozotocin therapy in 22 cancer patients. Cancer (1975) 0.83
Studies on adriamycin using a weekly regimen demonstrating its clinical effectiveness and lack of cardiac toxicity. Cancer Treat Rep (1976) 0.83
Preliminary pharmacokinetics of streptozotocin, an antineoplastic antibiotic. J Clin Pharmacol (1977) 0.83
Clinical trial with subcutaneously administered 5-azacytidine (NSC-102816). Cancer Chemother Rep (1974) 0.82
Absorption, distribution, and excretion of 5-azacytidine (NSC-102816) in man. Cancer Chemother Rep (1972) 0.81
Clinical studies with tubercidin administered after absorption into human erythrocytes. Cancer Res (1970) 0.81
Preoperative embolization of retroperitoneal hemangiopericytomas as an aid in their removal. Cancer (1982) 0.80
Intraarterial chemotherapy with limb-sparing resection of large soft-tissue sarcomas of the extremities. J Vasc Interv Radiol (1992) 0.78
Soft-tissue complications of intra-arterial chemotherapy for extremity sarcomas. Ann Plast Surg (1998) 0.77
Phase II study of 6 -methylpregn-4-ene-3,11,20-trione (NSC-17256). Cancer Chemother Rep (1971) 0.76
Hepatoma and hepatitis-associated antigen. Br Med J (1973) 0.75
Cytosine arabinoside (NSC 63878) toxicity and antitumor acitivity in human solid tumors. Oncology (1974) 0.75
Surviving and succeeding in the "political" organization: overcoming organizational myopia. Superv Manage (1978) 0.75
Reluctant patient. Special problems in psychologic treatment of patient with myelopathy. N Y State J Med (1968) 0.75
Phase I study of a combination of azotomycin (NSC-56654) and 5-fluorouracil (NSC-19893) in malignant disease. Cancer Chemother Rep (1970) 0.75
Evaluation of daunorubicin in adenocarcinoma of the large intestine. Cancer Treat Rep (1976) 0.75
The unmotivated patient. Arch Phys Med Rehabil (1968) 0.75
The absorption and metabolism of dibromodulcitol in patients with advanced cancer. Clin Pharmacol Ther (1972) 0.75
A phase I study of 6-azauridine (NSC-32074) in solid tumors. Cancer Chemother Rep (1969) 0.75
Fate of streptozotocin (NSC-85998)in patients with advanced cancer. Cancer Chemother Rep (1976) 0.75
Analysis of procarbazine and metabolites by gas chromatography-mass spectrometry. J Chromatogr (1980) 0.75
Surviving and succeeding in the "political" organization: becoming a leader. Superv Manage (1978) 0.75
Phase II study of carbestrol (NSC-19962) in patients with solid tumors. Cancer Chemother Rep (1972) 0.75
Adult invasive subcutaneous hemangioma. Otolaryngology (1979) 0.75
An improved method for isolating Ca2+-resistant myocytes from the adult rat heart. Res Commun Chem Pathol Pharmacol (1988) 0.75
A hypothesis concerning the effect of changes in scheduling upon the cardiotoxicity of adriamycin. Oncology (1983) 0.75
Phase I study of dibromodulcitol (NSC-104800). Cancer Chemother Rep (1971) 0.75
Psychologic adjustment of patients with myelopathy. Arch Phys Med Rehabil (1966) 0.75
Extremity osteosarcomas: intraarterial chemotherapy and limb-sparing resection with 2-year follow-up. Radiology (1990) 0.75
Prevention of stenosis after vaginal reconstruction using interdigitating flaps of skin and mucosa. Ann Plast Surg (1987) 0.75
How to influence people outside your control. Superv Manage (1977) 0.75
Phase I studies of porfiromycin (NSC--56410) in solid tumors. J Surg Oncol (1975) 0.75
Phase II study of dibromodulcitol (NSC-104800). Cancer Chemother Rep (1975) 0.75
Illness guilt, inadequacy guilt and rehabilitation therapy. Psychoanal Rev (1968) 0.75
Yoshi 864 (1-propanol, 3,3'-iminodi-, dimethanesulfonate [ester], hydrochloride): a phase II study in solid tumors. Cancer Treat Rep (1978) 0.75
Biliary sclerosis and the implanted pump. J Clin Oncol (1985) 0.75
Chemotherapy in ovarian malignancy: tumor sensitivity testing. Obstet Gynecol (1966) 0.75
A phase III study in lung carcinoma comparing hexamethyl-melamine (NSC 13875) to dibromodulcitol (NSC 104800) 1,2. Oncology (1975) 0.75
Phase I study of L-asparaginase (NSC 109229). Oncology (1975) 0.75
Evaluation of the combination of hexamethylmelamine (NSC-13875) and methotrexate (NSC-740) in carcinoma of the lung. Cancer Chemother Rep (1971) 0.75
Phase II study of azotomycin (NSC-56654). Cancer Chemother Rep (1968) 0.75